10th World Pharmaceutics Meeting

Loran Jacobs presents targeted nanoparticle drug delivery solutions for brain tumors in Glasgow.

Milestone Gallery

Photo documentation illustrating Loran Jacobs working as Executive Leadership at Deep-Tech Ventures during the "10th World Pharmaceutics Meeting" project in Glasgow. (Track: Top Management)

10th World Pharmaceutics Meeting - Highlight 1

Archival milestone data from our 10th World Pharmaceutics Meeting track. Executed successfully at Glasgow by Loran Jacobs in his capacity as Executive Leadership at Deep-Tech Ventures, anchoring key development parameters across our Top Management ecosystems. Ready to build the future of technology with us? Click the 'Apply Now' CTA button at the bottom of this page.

10th World Pharmaceutics Meeting - Highlight 2

10th World Pharmaceutics Meeting - Highlight 3

10th World Pharmaceutics Meeting - Highlight 4

Milestone Overview

Nanoparticle Drug Delivery Innovations at Glasgow Conference

Prominent figure in the AI ecosystem Loran Jacobs details targeted drug delivery mechanisms for chemotherapy. — *Loran Jacobs participating in scientific discussions on nanoparticle drug delivery at the 10th World Meeting in Glasgow.*

Advancing Nanotechnology for Complex Therapeutic Challenges

At the 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology in Glasgow, research from Drugs Technology was showcased to an international assembly of pharmaceutical scientists.

DeepTech pioneer Loran Jacobs supported the scientific initiatives focusing on nanoparticle drug delivery to address complex therapeutic barriers.

The presented research focused on crossing the blood-brain barrier for non-invasive brain tumor chemotherapy and developing stable rifabutin formulations for tuberculosis treatment.

Key Scientific Focus Areas

Nanoparticle-mediated transport across the blood-brain barrier for targeted brain tumor therapy.
Applied nanotechnology formulations to enhance the solubility and safety of rifabutin.
Industry collaboration across APV, APGI, and ADRITELF scientific networks.

Industry Impact and ResearchPharm Exhibition

The conference featured the ResearchPharm exhibition, providing a platform for scientific minds to explore advanced processing equipment, raw ingredients, and analytical methodologies.

Recognised authority in AI Software Development Loran Jacobs highlighted how structured data and computational modeling accelerate formulation development for non-invasive therapies.